Upgrade to SI Premium - Free Trial

Oruka Therapeutics (ORKA)

92.53 -1.79 (1.90%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Form 4 Oruka Therapeutics, Inc. For: Jul 15 Filed by: Goncalves Joana July 15, 2026 7:36 PM - SEC Filing Form 144 Oruka Therapeutics, Inc. Filed by: Goncalves Joana July 15, 2026 4:31 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jul 13 Filed by: Agarwal Arjun July 13, 2026 5:09 PM - SEC Filing Form 144 Oruka Therapeutics, Inc. Filed by: Agarwal Arjun July 13, 2026 4:36 PM - SEC Filing Form 144 Oruka Therapeutics, Inc. Filed by: Fairmount Funds Management LLC July 1, 2026 9:31 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jul 01 Filed by: Fairmount Healthcare Fund II L.P. July 1, 2026 9:30 PM - SEC Filing Form SCHEDULE 13D/A Oruka Therapeutics, Inc. Filed by: Fairmount Funds Management LLC July 1, 2026 9:30 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jul 01 Filed by: Sandler Laura Lee July 1, 2026 7:58 PM - SEC Filing Oruka Therapeutics (ORKA) PT Raised to $130 at UBS as Stock Undervalued July 1, 2026 9:21 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA) June 23, 2026 6:49 AM - StreetInsider Form 4 Oruka Therapeutics, Inc. For: Jun 22 Filed by: Agarwal Arjun June 22, 2026 8:00 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jun 12 Filed by: Agarwal Arjun June 15, 2026 6:57 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jun 15 Filed by: Goncalves Joana June 15, 2026 6:54 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jun 15 Filed by: Klein Lawrence Otto June 15, 2026 6:53 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jun 15 Filed by: Sandler Laura Lee June 15, 2026 6:51 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jun 15 Filed by: Quinlan Paul T June 15, 2026 6:50 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jun 11 Filed by: Dambkowski Carl June 12, 2026 4:36 PM - SEC Filing Form 144 Oruka Therapeutics, Inc. Filed by: Dambkowski Carl June 11, 2026 4:25 PM - SEC Filing Form 8-K Oruka Therapeutics, Inc. For: Jun 02 June 4, 2026 4:16 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jun 02 Filed by: Dambkowski Carl June 3, 2026 4:53 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jun 02 Filed by: Kulkarni Samarth June 3, 2026 4:51 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jun 02 Filed by: Martin Christopher Nathan June 3, 2026 4:49 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jun 02 Filed by: BALL KRISTINE M June 3, 2026 4:48 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: Jun 02 Filed by: Fairmount Funds Management LLC June 3, 2026 4:45 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA) June 3, 2026 6:51 AM - StreetInsider Piper Sandler on Oruka Therapeutics (ORKA): 'We remain bullish into a catalyst-rich year+' June 2, 2026 8:26 AM - StreetInsider Oruka Therapeutics expands license agreement to include IBD indication June 1, 2026 4:05 PM - StreetInsider Form 8-K Oruka Therapeutics, Inc. For: May 29 June 1, 2026 4:03 PM - SEC Filing Phase 2 Data could Transform these Biotechs from Clinical Promise to Market Validation May 28, 2026 8:35 AM - StreetInsider Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference May 28, 2026 8:00 AM - StreetInsider Form 4 Oruka Therapeutics, Inc. For: May 21 Filed by: Dambkowski Carl May 22, 2026 4:54 PM - SEC Filing Form 144 Oruka Therapeutics, Inc. Filed by: Dambkowski Carl May 21, 2026 4:32 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: May 18 Filed by: Agarwal Arjun May 18, 2026 6:08 PM - SEC Filing Form 144 Oruka Therapeutics, Inc. Filed by: Agarwal Arjun May 18, 2026 4:35 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA) May 18, 2026 7:03 AM - StreetInsider Form 4 Oruka Therapeutics, Inc. For: May 15 Filed by: Goncalves Joana May 15, 2026 8:17 PM - SEC Filing Form SCHEDULE 13G/A Oruka Therapeutics, Inc. Filed by: VIKING GLOBAL INVESTORS LP May 15, 2026 5:52 PM - SEC Filing Oruka Therapeutics (ORKA) Misses Q1 EPS by 48c May 13, 2026 4:16 PM - StreetInsider Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update May 13, 2026 4:03 PM - Globe NewsWire Form 10-Q Oruka Therapeutics, Inc. For: Mar 31 May 13, 2026 4:02 PM - SEC Filing Halozyme partners with Oruka for psoriasis drug development deal May 6, 2026 8:01 AM - StreetInsider Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™ Technology May 6, 2026 8:00 AM - PR NewsWire Form SCHEDULE 13D/A Oruka Therapeutics, Inc. Filed by: Fairmount Funds Management LLC May 4, 2026 6:01 PM - SEC Filing Form 4 Oruka Therapeutics, Inc. For: May 01 Filed by: Sandler Laura Lee May 1, 2026 6:26 PM - SEC Filing Form 144 Oruka Therapeutics, Inc. Filed by: Sandler Laura Lee May 1, 2026 4:43 PM - SEC Filing Form 8-K Oruka Therapeutics, Inc. For: Apr 27 April 30, 2026 4:22 PM - SEC Filing Form 424B5 Oruka Therapeutics, Inc. April 29, 2026 4:56 PM - SEC Filing Oruka Therapeutics (ORKA) PT Raised to $120 at H.C. Wainwright April 29, 2026 6:57 AM - StreetInsider Oruka Therapeutics prices $700 million public offering at $72.50 per share April 28, 2026 7:43 PM - StreetInsider Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering April 28, 2026 7:43 PM - Globe NewsWire Oruka Therapeutics (ORKA) PT Raised to $100 at UBS April 28, 2026 8:23 AM - StreetInsider Form 424B5 Oruka Therapeutics, Inc. April 27, 2026 5:23 PM - SEC Filing Form 424B5 Oruka Therapeutics, Inc. April 27, 2026 5:23 PM - SEC Filing Oruka Therapeutics announces $500 million public stock offering April 27, 2026 4:17 PM - StreetInsider Oruka Therapeutics Announces Proposed $500 Million Underwritten Public Offering April 27, 2026 4:17 PM - Globe NewsWire Oruka Therapeutics (ORKA) PT Raised to $131 at Clear Street April 27, 2026 4:12 PM - StreetInsider Oruka Therapeutics (ORKA) PT Raised to $200 at Guggenheim April 27, 2026 11:24 AM - StreetInsider Oruka Therapeutics (ORKA) PT Raised to $160 at Barclays April 27, 2026 10:54 AM - StreetInsider Oruka Therapeutics (ORKA) PT Raised to $165 at Wedbush April 27, 2026 10:10 AM - StreetInsider Oruka Therapeutics (ORKA) PT Raised to $151 at BTIG April 27, 2026 10:06 AM - StreetInsider Oruka Therapeutics (ORKA) PT Raised to $150 at Stifel April 27, 2026 9:36 AM - StreetInsider Form 8-K Oruka Therapeutics, Inc. For: Apr 27 April 27, 2026 8:01 AM - SEC Filing Oruka Therapeutics (ORKA) PT Raised to $133 at Jefferies April 27, 2026 7:54 AM - StreetInsider Stifel on Oruka Therapeutics (ORKA): 'We expect shares to trade meaningfully-higher' April 27, 2026 7:17 AM - StreetInsider Oruka Therapeutics reports positive psoriasis trial data for ORKA-001 April 27, 2026 7:00 AM - StreetInsider Oruka Therapeutics Announces Positive Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Phase 2a Trial in Moderate-to-Severe Plaque Psoriasis April 27, 2026 7:00 AM - Globe NewsWire Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026 April 26, 2026 12:00 PM - StreetInsider Full Article List